CLOV

Clover Health Investments Corp. Healthcare - Insurance Investor Relations โ†’

NO
2.3% ABOVE
โ†“ Approaching Was 7.3% last week
-15% -10% -5% 0% 5% 10% 15%+
Buy Threshold $2.08
14-Week RSI 24 ๐Ÿ“‰

Clover Health Investments Corp. (CLOV) closed at $2.13 as of 2026-02-02, trading 2.3% above its 200-week moving average of $2.08. The stock is currently moving closer to the line, down from 7.3% last week. With a 14-week RSI of 24, CLOV is in oversold territory.

Over the past 247 weeks of data, CLOV has crossed below its 200-week moving average 5 times. On average, these episodes lasted 35 weeks. The average one-year return after crossing below was -41.7%, suggesting these dips have not historically been reliable buying opportunities for this stock.

With a market cap of $1101 million, CLOV is a small-cap stock. Free cash flow yield is currently negative, meaning the company is burning cash. Return on equity stands at -16.9%. The stock trades at 3.2x book value.

Share count has increased 6.9% over three years, indicating dilution.

Over the past 4.8 years, a hypothetical investment of $100 in CLOV would have grown to $24, compared to $176 for the S&P 500. CLOV has returned -25.8% annualized vs 12.3% for the index, underperforming the broader market over this period.

In the past 12 months, corporate insiders have made 2 open-market purchases totaling $1,067,752.

Free cash flow has been volatile over the past several years, making the quality of earnings harder to assess.

Growth of $100: CLOV vs S&P 500

Monthly data normalized to $100 at start. Vertical dashed lines mark 200-week MA touches.

What Happens After CLOV Crosses Below the Line?

Across 5 historical episodes, buying CLOV when it crossed below its 200-week moving average produced an average return of -48.0% after 12 months (median -28.0%), compared to +7.0% for the S&P 500 over the same periods. After 24 months, the average return was -87.0% vs +5.0% for the index.

Each line shows $100 invested at the moment CLOV crossed below its 200-week MA. Bold blue = stock average. Gray dashed = S&P 500 average over same periods.

Advertisement

Insider Buying Activity

1 conviction buy in the past 12 months (purchases over $500K with meaningful position increases).

DateInsiderTitleValueSharesPosition +%
2025-08-08GARIPALLI VIVEKDirector and Beneficial Owner of more than 10% of a Class of Security$998,997446,980+31.7%

Historical Touches

CLOV has crossed below its 200-week MA 5 times with an average 1-year return of +-41.7% after recovery.

Crossed BelowRecoveredWeeksMax Depth1-Year ReturnReturn Since Touch
May 2021Jun 2021335.4%-60.5%-69.3%
Jul 2021Sep 202416988.0%-71.4%-77.0%
Nov 2024Nov 2024210.7%-21.7%-37.5%
Dec 2024Dec 202413.1%-13.2%-31.5%
Aug 2025Aug 202514.5%N/A-2.3%
Average35โ€”+-41.7%โ€”

Not financial advice. This is an educational tool. Past performance does not guarantee future results. Do your own research before making investment decisions.

Data as of Friday close, 2026-02-02